Analyst Ratings For NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
Today, Leerink Swann reiterated its Outperform rating on NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH) with a price target of $20.00 ➝ $12.00.
Some recent analyst ratings include
- 6/14/2018-Leerink Swann Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH) has insider ownership of 4.80% and institutional ownership of 44.87%.
- On 11/21/2017 5Am Partners Iv, Llc, Major Shareholder, bought 654,762 with an average share price of $14.00 per share and the total transaction amounting to $9,166,668.00.
Recent Trading Activity for NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
Shares of NASDAQ:SCPH – Scpharmaceuticals closed the previous trading session at 6.02 up +0.09 1.52% with shares trading hands.